Cargando…
Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
The low resection and high recurrence rates in hepatocellular carcinoma (HCC) are the major challenges to improving prognosis. Neoadjuvant and conversion therapies are underlying strategies to overcome these challenges. To date, no guideline or consensus has been published on the neoadjuvant and con...
Autores principales: | Zhao, Hai-Tao, Cai, Jian-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704274/ https://www.ncbi.nlm.nih.gov/pubmed/35068855 http://dx.doi.org/10.3748/wjg.v27.i47.8069 |
Ejemplares similares
-
Expert consensus of Chinese Association for the Study of Pain on the application of ozone therapy in pain medicine
por: Zhuang, Zhi-Gang, et al.
Publicado: (2021) -
Expert consensus of Chinese Association for the Study of Pain on the radiofrequency therapy technology in the Department of Pain
por: Liu, Jin-Feng, et al.
Publicado: (2021) -
Chinese Association for the Study of Pain: Expert consensus on chronic postsurgical pain
por: Liu, Yi-Ming, et al.
Publicado: (2021) -
Expert consensus of Chinese Association for the Study of Pain on the non-opioid analgesics for chronic musculoskeletal pain
por: Huang, Dong, et al.
Publicado: (2021) -
Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain
por: Xiao, Hong, et al.
Publicado: (2021)